Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site footer revision changes from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T00:41:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the olaparib trial in BRCA-mutated ovarian cancer, including its design, eligibility criteria, outcomes, locations, and data-sharing resources, replacing a 403 error page.
    Difference
    98%
    Check dated 2026-11-10T18:30:37.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now lists revision v3.8.0 instead of v3.7.2. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T18:47:38.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the terminology transition appears above the study record, and the site revision advances from v3.7.1 to v3.7.2. The study record itself remains a 403 error page.
    Difference
    1%
    Check dated 2026-10-20T18:58:31.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The footer identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-06T19:44:05.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with an access-denied message.
    Difference
    17%
    Check dated 2026-09-22T20:40:06.000Z thumbnail image

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.